Biotech

All Articles

Orion to make use of Aitia's 'electronic twins' to find brand-new cancer medications

.Finnish biotech Orion has spied possible in Aitia's "digital double" technology to cultivate brand-...

Windtree's surprise med rears blood pressure in most recent phase 2 gain

.While Windtree Rehabs has battled to increase the monetary roots needed to have to make it through,...

2 cancer biotechs merge, making global impact

.OncoC4 is actually taking AcroImmune-- and its internal clinical production capabilities-- under it...

Amgen records very first period 3 gain for $400M eczema medication

.Amgen has actually shared (PDF) the initial period 3 information on its $400 million dermatitis med...

Biogen, UCB record period 3 lupus gain after stopping working earlier test

.Biogen as well as UCB's bet one's bottom dollar improving right into period 3 on the back of a fail...

Aptadir hopes new RNA inhibitors may turn around difficult cancers

.Italian biotech Aptadir Rehabs has introduced with the guarantee that its pipeline of preclinical R...

Wave surfs DMD success to regulatory authorities' doors, delivering stock up

.Wave Life Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD) resea...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, taking up the ...